CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group - Pfreundschuh, M; Trümper, L; Osterborg, A (Lancet Oncol, 2006)
, et al; MabThera International Trial Group.